<p>Tianjin Development Holdings Limited announced that its affiliate, Tianjin Lisheng Pharmaceutical Co., Ltd., in which it holds an approximately 34.11% indirect stake, has released indicative results for the year 2025. According to a preliminary estimation by Lisheng Pharmaceutical’s finance department, the company expects an increase in results over the previous year. The final results will be detailed in the 2025 Annual Report. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin Development Holdings Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260123-11999816), on January 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

002393

Lisheng Pharmaceutical, Tianjin Development Holdings Affiliate, Reports Indicative 2025 Earnings Growth